General Information of the Protein
Protein ID
PT01625
Protein Name
Cathepsin D
Gene Name
CTSD
Secondarily
Gene Name
CPSD
Sequence
MQPSSLLPLALCLLAAPASALVRIPLHKFTSIRRTMSEVGGSVEDLIAKGPVSKYSQAVPAVTEGPIPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSDKSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQSASSASALGGVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIFSFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEGCEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKLSPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEAARL
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Protease
>
Aspartic protease
>
Aspartic protease AA clan
>
Aspartic protease A1A subfamily
Function
Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation (PubMed:27333034). Involved in the pathogenesis of several diseases such as breast cancer and possibly Alzheimer disease.
    Show/Hide
Uniprot ID
Primary ID:
P07339

Secondarily ID:
Q6IB57
    Show/Hide
Ensembl ID
ENSG00000117984
HGNC ID
HGNC:2529
Subcellular Location
Lysosome
Melanosome
Secreted
Extracellular space
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0551183
(4S)-3'-(3,6-dihydro-2H-pyran-5-yl)-1'-fluoro-7'-(2-fluoropyridin-3-yl)spiro[5H-1,3-oxazole-4,5'-chromeno[2,3-c]pyridine]-2-amine
   Show/Hide
C24H18F2N4O3
 1
1
IC50 = 93 nM
   TI
   LI
   LO
   TS
CP0935597
N-((2R,3S)-3-{[(7-Ethyl-1-methyl-2,2-dioxido-3,4-dihydro-1H-[1,2,5]thiadiazepino[3,4,5-hi]indol-9-yl)carbonyl]amino}-2-hydroxy-4-phenylbutyl)-2,6-dimethyl-2-heptanaminium formate
   Show/Hide
C34H50N4O6S
 1
1
IC50 = 660 nM
   TI
   LI
   LO
   TS
CP0943195
N-((2R,3S)-3-{[(7-Ethyl-1-methyl-2,2-dioxido-3,4-dihydro-1H-[1,2,5]thiadiazepino[3,4,5-hi]indol-9-yl)carbonyl]amino}-2-hydroxy-4-phenylbutyl)cyclohexanaminium formate
   Show/Hide
C31H42N4O6S
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0262731
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)-N-[(2S,3R)-3-hydroxy-4-[(6-methoxy-2,3-dihydro-1H-inden-1-yl)amino]-1-phenylbutan-2-yl]benzamide
   Show/Hide
C33H42N4O5S
 1
1
IC50 = 1070 nM
   TI
   LI
   LO
   TS
CP0876278
(2R,3S)-3-{[(7-Ethyl-1-methyl-2,2-dioxido-3,4-dihydro-1H-[1,2,5]thiadiazepino[3,4,5-hi]indol-9-yl)carbonyl]amino}-2-hydroxy-4-phenyl-N-{[3-(trifluoromethyl)phenyl]methyl}-1-butanaminium formate
   Show/Hide
C33H37F3N4O6S
 1
1
IC50 = 1260 nM
   TI
   LI
   LO
   TS
CP0511437
3-ethoxy-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]-5-(2-methyl-5-oxocyclopent-1-en-1-yl)benzamide
   Show/Hide
C33H35F3N2O4
 1
1
IC50 = 1750 nM
   TI
   LI
   LO
   TS
CP0489362
3-(2-cyanophenyl)-5-ethoxy-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]benzamide
   Show/Hide
C34H32F3N3O3
 1
1
IC50 = 2020 nM
   TI
   LI
   LO
   TS
CP0876281
N-[(2R,3S)-3-({[3-(1,1-Dioxidotetrahydro-2H-1,2-thiazin-2-yl)-5-(ethylamino)phenyl]carbonyl}amino)-2-hydroxy-4-phenylbutyl]-2,6-dimethyl-2-heptanaminium formate
   Show/Hide
C34H54N4O6S
 1
1
IC50 = 2340 nM
   TI
   LI
   LO
   TS
CP0464299
N-[(2S,3R)-1-(3,5-difluorophenyl)-3-hydroxy-4-{[(3-methoxyphenyl)methyl]amino}butan-2-yl]-3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)benzamide
   Show/Hide
C31H38F2N4O5S
 1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0457705
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethoxy)phenyl]methyl}amino)butan-2-yl]benzamide
   Show/Hide
C31H37F3N4O5S
 1
1
IC50 = 2570 nM
   TI
   LI
   LO
   TS
CP0170144
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)-2-fluoro-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]benzamide
   Show/Hide
C31H36F4N4O4S
 1
1
IC50 = 2653 nM
   TI
   LI
   LO
   TS
CP0464298
3-(2-acetylphenyl)-5-ethoxy-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]benzamide
   Show/Hide
C35H35F3N2O4
 1
1
IC50 = 2940 nM
   TI
   LI
   LO
   TS
CP0486753
N-[(2S,3R)-4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-3-hydroxy-1-phenylbutan-2-yl]-3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)benzamide
   Show/Hide
C32H40N4O4S
 1
1
IC50 = 3090 nM
   TI
   LI
   LO
   TS
CP0230205
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]benzamide
   Show/Hide
C31H37F3N4O4S
 1
1
IC50 = 3900 nM
   TI
   LI
   LO
   TS
CP0935596
(2R,3S)-3-({[3-(1,1-Dioxidotetrahydro-2H-1,2-thiazin-2-yl)-5-(ethylamino)phenyl]carbonyl}amino)-2-hydroxy-4-phenyl-N-{[3-(trifluoromethyl)phenyl]methyl}-1-butanaminium formate
   Show/Hide
C32H39F3N4O6S
 1
1
IC50 = 3900 nM
   TI
   LI
   LO
   TS
CP0454076
3-(1,1-dioxo-1,2-thiazinan-2-yl)-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]-5-propylbenzamide
   Show/Hide
C32H38F3N3O4S
 1
1
IC50 = 4790 nM
   TI
   LI
   LO
   TS
CP0876279
N-[(2R,3S)-3-({[3-(1,1-Dioxidotetrahydro-2H-1,2-thiazin-2-yl)-5-ethylamino)phenyl]carbonyl}amino)-2-hydroxy-4-phenylbutyl]cyclohexanaminiumformate
   Show/Hide
C30H44N4O6S
 1
1
IC50 = 5250 nM
   TI
   LI
   LO
   TS
CP0454070
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-ethoxy-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]benzamide
   Show/Hide
C31H36F3N3O5S
 1
1
IC50 = 5890 nM
   TI
   LI
   LO
   TS
CP0457720
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-ethoxy-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethoxy)phenyl]methyl}amino)butan-2-yl]benzamide
   Show/Hide
C31H36F3N3O6S
 1
1
IC50 = 6170 nM
   TI
   LI
   LO
   TS
CP0455072
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)-2-fluoro-N-[(2S,3R)-3-hydroxy-4-{[(3-methoxyphenyl)methyl]amino}-1-phenylbutan-2-yl]benzamide
   Show/Hide
C31H39FN4O5S
 1
1
IC50 = 6545 nM
   TI
   LI
   LO
   TS
CP0454075
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)-N-[(2S,3R)-3-hydroxy-4-{[(3-methoxyphenyl)methyl]amino}-1-phenylbutan-2-yl]benzamide
   Show/Hide
C31H40N4O5S
 1
1
IC50 = 6760 nM
   TI
   LI
   LO
   TS
CP0040694
BMCL193669 Compound 18
   Show/Hide
C27H34N4O4S
 1
1
IC50 = 7933 nM
   TI
   LI
   LO
   TS
CP0455080
3-(1,1-dioxo-1,2-thiazolidin-2-yl)-5-ethoxy-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]benzamide
   Show/Hide
C30H34F3N3O5S
 1
1
IC50 = 8510 nM
   TI
   LI
   LO
   TS
CP0418135
US9085576, 234
   Show/Hide
C19H17F4N5O2
 1
1
IC50 > 14800 nM
   TI
   LI
   LO
   TS
CP0575620
US9085576, 350
   Show/Hide
C21H14ClF3N6O
 1
1
IC50 > 14800 nM
   TI
   LI
   LO
   TS
CP0312779
US9296734, 18
   Show/Hide
C20H14F8N6O
 1
1
IC50 > 14800 nM
   TI
   LI
   LO
   TS
CP0518494
US9296734, 122
   Show/Hide
C19H22F6N4O2
 1
1
IC50 > 14800 nM
   TI
   LI
   LO
   TS
CP0454079
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)-N-[(2S,3R)-1-(furan-2-yl)-3-hydroxy-4-{[(3-methoxyphenyl)methyl]amino}butan-2-yl]benzamide
   Show/Hide
C29H38N4O6S
 1
1
IC50 = 15140 nM
   TI
   LI
   LO
   TS
CP0897223
N-[(2S,3R)-4-(benzylamino)-3-hydroxy-1-phenylbutan-2-yl]-3-ethyl-9-methyl-10,10-dioxo-10lambda6-thia-1,9-diazatricyclo[6.4.1.04,13]trideca-2,4(13),5,7-tetraene-6-carboxamide;formic acid
   Show/Hide
C32H38N4O6S
 1
1
IC50 = 17180 nM
   TI
   LI
   LO
   TS
CP0220256
US9085576, 369
   Show/Hide
C21H18F3N3O
 1
1
IC50 = 19200 nM
   TI
   LI
   LO
   TS
CP0489349
3-(1,1-dioxo-1,2-thiazinan-2-yl)-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]-5-(propan-2-ylamino)benzamide
   Show/Hide
C32H39F3N4O4S
 1
1
IC50 = 25120 nM
   TI
   LI
   LO
   TS
CP0454078
BMCL181022 Compound 12
   Show/Hide
C30H38N4O4S
 1
1
IC50 = 26300 nM
   TI
   LI
   LO
   TS
CP0897224
(2R,3S)-3-({[3-(1,1-Dioxidotetrahydro-2H-1,2-thiazin-2-yl)-5-(ethylamino)phenyl]carbonyl}amino)-2-hydroxy-4-phenyl-N-(phenylmethyl)-1-butanaminium formate
   Show/Hide
C31H40N4O6S
 1
1
IC50 = 26300 nM
   TI
   LI
   LO
   TS
CP0894683
N-[(2R,3S)-3-({[3-(1,1-Dioxidotetrahydro-2H-1,2-thiazin-2-yl)-5-(ethylamino)phenyl]carbonyl}amino)-2-hydroxy-4-phenylbutyl]cyclopropanaminiumformate
   Show/Hide
C27H38N4O6S
 1
1
IC50 = 30200 nM
   TI
   LI
   LO
   TS
CP0501733
3-ethoxy-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]-5-(2-oxopyrrolidin-1-yl)benzamide
   Show/Hide
C31H34F3N3O4
 1
1
IC50 = 34325 nM
   TI
   LI
   LO
   TS
CP0227472
US9085576, 317
   Show/Hide
C20H16ClF2N5O3
 1
1
IC50 = 41000 nM
   TI
   LI
   LO
   TS
CP0334908
US9296734, 10
   Show/Hide
C21H14F6N6O
 1
1
IC50 > 44000 nM
   TI
   LI
   LO
   TS
CP0325626
US9085576, 363
   Show/Hide
C21H15ClF2N6O
 1
1
IC50 > 44400 nM
   TI
   LI
   LO
   TS
CP0342488
US9085576, 365
   Show/Hide
C20H14F6N6O
 1
1
IC50 > 44400 nM
   TI
   LI
   LO
   TS
CP0351266
US9085576, 343
   Show/Hide
C21H15F3N6O
 1
1
IC50 > 44400 nM
   TI
   LI
   LO
   TS
CP0491646
US9296734, 105
   Show/Hide
C19H13ClF5N3O2
 1
1
IC50 > 44400 nM
   TI
   LI
   LO
   TS
CP0234609
N-[3-[(1S,5S,6S)-3-amino-1-(difluoromethyl)-5-methyl-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4,5-difluorophenyl]-5-prop-2-ynoxypyrazine-2-carboxamide
   Show/Hide
C21H17F4N5O2S
 1
1
IC50 = 48000 nM
   TI
   LI
   LO
   TS
CP0575611
US9085576, 240
   Show/Hide
C15H16F3N3O3
 1
1
IC50 = 48150 nM
   TI
   LI
   LO
   TS
CP0274641
US9085576, 342
   Show/Hide
C20H15ClF3N5O
 1
1
IC50 = 50550 nM
   TI
   LI
   LO
   TS
CP0342492
US9085576, 221
   Show/Hide
C20H16ClF2N5O3
 1
1
IC50 = 51050 nM
   TI
   LI
   LO
   TS
CP0565147
US9085576, 376
   Show/Hide
C17H17F6N3O
 1
1
IC50 = 52900 nM
   TI
   LI
   LO
   TS
CP0519921
US9296734, 11
   Show/Hide
C19H14ClF5N6O
 1
1
IC50 = 54400 nM
   TI
   LI
   LO
   TS
CP0138372
3-(1,1-dioxo-1,2-thiazinan-2-yl)-N-[(2S,3R)-4-{[(1-ethyl-1H-pyrazol-4-yl)methyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-5-(ethylamino)benzamide
   Show/Hide
C29H40N6O4S
 1
1
IC50 = 56230 nM
   TI
   LI
   LO
   TS
CP0488860
US9085576, 338
   Show/Hide
C21H20FN5O2
 1
1
IC50 = 56550 nM
   TI
   LI
   LO
   TS
CP0117164
US9085576, 168
   Show/Hide
C17H14F4N4O3
 1
1
IC50 = 56750 nM
   TI
   LI
   LO
   TS
CP0876280
(2R,3S)-3-{[(7-Ethyl-1-methyl-2,2-dioxido-3,4-dihydro-1H-[1,2,5]thiadiazepino[3,4,5-hi]indol-9-yl)carbonyl]amino}-2-hydroxy-N-methyl-4-phenyl-1-butanaminium formate
   Show/Hide
C26H34N4O6S
 1
1
IC50 = 58880 nM
   TI
   LI
   LO
   TS
CP0351270
US9085576, 370
   Show/Hide
C22H21ClF3N3O
 1
1
IC50 = 63600 nM
   TI
   LI
   LO
   TS
CP0522613
US9085576, 422
   Show/Hide
C19H15ClF6N4O
 1
1
IC50 = 68200 nM
   TI
   LI
   LO
   TS
CP0243743
US9085576, 378
   Show/Hide
C19H18ClF3N4O
 1
1
IC50 = 77400 nM
   TI
   LI
   LO
   TS
CP0239240
US9085576, 250
   Show/Hide
C24H21F3N4O3
 1
1
IC50 = 77500 nM
   TI
   LI
   LO
   TS
CP0117157
US9085576, 375
   Show/Hide
C18H20F3N3O
 1
1
IC50 = 78850 nM
   TI
   LI
   LO
   TS
CP0333537
US9085576, 449
   Show/Hide
C20H14F6N6O
 1
1
IC50 = 79350 nM
   TI
   LI
   LO
   TS
CP0266541
US9085576, 116
   Show/Hide
C18H13BrF4N4O2
 1
1
IC50 = 81884 nM
   TI
   LI
   LO
   TS
CP0243684
US9085576, 384
   Show/Hide
C21H19BrF3N3O
 1
1
IC50 = 82550 nM
   TI
   LI
   LO
   TS
CP0117156
US9085576, 372
   Show/Hide
C22H22F3N3O
 1
1
IC50 = 85450 nM
   TI
   LI
   LO
   TS
CP0243695
US9085576, 140
   Show/Hide
C21H17ClF2N4O3
 1
1
IC50 = 86900 nM
   TI
   LI
   LO
   TS
CP0455071
3-(1,1-dioxo-1,2-thiazinan-2-yl)-N-[(2S,3R)-4-{[(1-ethyl-1H-pyrazol-4-yl)methyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-5-(ethylamino)-2-fluorobenzamide
   Show/Hide
C29H39FN6O4S
 1
1
IC50 = 87100 nM
   TI
   LI
   LO
   TS
CP0477231
US9085576, 63
   Show/Hide
C19H18F3N5O3
 1
1
IC50 = 99750 nM
   TI
   LI
   LO
   TS
CP0464295
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)-N-[(2S,3R)-3-hydroxy-4-{[(3-methoxyphenyl)methyl]amino}-1-(1H-pyrazol-1-yl)butan-2-yl]benzamide
   Show/Hide
C28H38N6O5S
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0890931
3-(1,1-dioxo-1lambda*6*-[1,2]thiazinan-2-yl)-5-ethylamino-N-[(1S,2R)-2-hydroxy-1-isopropyl-3-(3-methoxy-benzylamino)-propyl]-benzamide
   Show/Hide
C27H40N4O5S
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0880740
(2R,3S)-3-({[3-(1,1-Dioxidotetrahydro-2H-1,2-thiazin-2-yl)-5-(ethylamino)phenyl]carbonyl}amino)-2-hydroxy-N-methyl-4-phenyl-1-butanaminium chloride
   Show/Hide
C24H35ClN4O4S
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0024522
N-[(2S)-1-[(3-fluoro-2-oxopropyl)amino]-1-oxo-3-phenylpropan-2-yl]benzamide
   Show/Hide
C19H19FN2O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0030570
benzyl N-[(2S)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate
   Show/Hide
C21H23FN2O4
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0034074
N-[(2S)-1-[(3-fluoro-2-oxopropyl)amino]-1-oxo-3-phenylpropan-2-yl]naphthalene-1-carboxamide
   Show/Hide
C23H21FN2O3
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0142132
US9085576, 180
   Show/Hide
C19H16F4N4O3
 1
1
IC50 > 1650 nM
   TI
   LI
   LO
   TS
CP0062694
US9296734, 177
   Show/Hide
C21H14F6N6O
 1
1
IC50 > 4940 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0035593
(3S,4S)-3-hydroxy-4-[(2S)-2-[(3S,4S)-3-hydroxy-6-methyl-4-[(2S)-3-methyl-2-[(2S)-3-methyl-2-(3-methylbutanamido)butanamido]butanamido]heptanamido]propanamido]-6-methylheptanoic acid
   Show/Hide
C34H63N5O9
 8
1 IC50 = 0.05 nM
2 IC50 = 0.173 nM
3 IC50 = 0.55 nM
4 IC50 = 0.693 nM
5 IC50 < 1 nM
6 IC50 = 2.3 nM
7 IC50 = 2.332702 nM
8 Ki = 0.01 nM
CP0079652
methyl (2S)-1-[(2R)-2-[[(2S)-2-[[(2S,3S)-2-[[(3S,4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[(2S)-2-(dimethylamino)-3-phenylpropanoyl]oxypropanoyl]amino]-4-methylpentanoyl]-methylamino]-5-oxopentanoyl]amino]-3-hydroxy-6-methylheptanoyl]amino]-3-methylpentanoyl]amino]propanoyl]-methylamino]-3-phenylpropanoyl]pyrrolidine-2-carboxylate
   Show/Hide
C59H91N9O13
 1
1 IC50 = 5.5 nM
CP0061358
methyl (2S)-1-[(2R)-2-[[(2S)-2-[[(2S,3R)-2-[[(3S,4S)-4-[[(2S)-4-amino-2-[[(2S)-2-[[(2R)-2-[(2S)-2-[(2S)-2-(dimethylamino)-3-methylbutanoyl]oxy-3-methylbutanoyl]oxy-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxy-6-methylheptanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]-methylamino]-3-phenylpropanoyl]pyrrolidine-2-carboxylate
   Show/Hide
C58H95N9O16
 3
1 IC50 = 26.5 nM
2 IC50 = 40 nM
3 IC50 = 10000 nM
CP0262731
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)-N-[(2S,3R)-3-hydroxy-4-[(6-methoxy-2,3-dihydro-1H-inden-1-yl)amino]-1-phenylbutan-2-yl]benzamide
   Show/Hide
C33H42N4O5S
 1
1 IC50 = 1070 nM
CP0230205
3-(1,1-dioxo-1,2-thiazinan-2-yl)-5-(ethylamino)-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]benzamide
   Show/Hide
C31H37F3N4O4S
 2
1 IC50 = 3570 nM
2 IC50 = 6760 nM
CP0241554
methyl (2S)-1-[(2R)-2-[[(2S)-2-[[(2S,3S)-2-[[(3S,4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-hydroxypropanoyl]amino]-4-methylpentanoyl]-methylamino]-5-oxopentanoyl]amino]-3-hydroxy-6-methylheptanoyl]amino]-3-methylpentanoyl]amino]propanoyl]-methylamino]-3-phenylpropanoyl]pyrrolidine-2-carboxylate
   Show/Hide
C48H78N8O12
 1
1 IC50 = 5500 nM
CP0040694
BMCL193669 Compound 18
   Show/Hide
C27H34N4O4S
 1
1 IC50 = 7930 nM
Clinical Information about the Protein
Target 1 ( Cathepsin D (CTSD) )
Target Type Clinical trial Target
Disease 2 Target-related Diseases  2
1 Multiple sclerosis [ICD-11: 8A40]
2 Hypertension [ICD-11: BA00-BA04]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 PMID10498202C1 Clinical trial
Multiple sclerosis
Discontinued Drug(s) 1 Discontinued Drug  1
1 CI-992 Terminated
Hypertension